ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Disease Activity"

  • Abstract Number: 1947 • 2013 ACR/ARHP Annual Meeting

    The 7-Joint Ultrasound Score Is a Feasible Tool For Evaluating Joint Inflammation In Rheumatoid Arthritis Patients. Experience Among Rheumatologists With Basic Or Intermediate Level Of Ultrasound Training

    Jana Hurnakova1,2, Jakub Zavada2,3, Herman F. Mann1,2, Ladislav Senolt2,4, Martin Klein2,4, Petra Hanova5,6, Sarka Forejtova2,4, Marta Olejarova2,4, Olga Ruzickova2,4, Olga Sleglova2,4 and Karel Pavelka2,7, 1Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Prague, Czech Republic, 21st Faculty of Medicine, Charles University, Prague, Prague, Czech Republic, 3Charles University, Prague, Czech Republic, 4Institute of Rheumatology, Prague, Prague, Czech Republic, 5Institute of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Prague, Czech Republic, 61st Faculty of Medicine, Charles University, Prague, Czech Republic, 7Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic

    Background/Purpose: Musculoskeletal ultrasound plays an increasingly important role in monitoring disease activity and therapy response. German US-7 score is a recently introduced ultrasound scoring index…
  • Abstract Number: 1519 • 2013 ACR/ARHP Annual Meeting

    Meeting The ACR 2010 Fibromyalgia Criteria Worsens Disease Activity and Quality Of Life In Patients With Axial Spondyloarthritis Treated With Infliximab

    Mathieu Verdet1, Clément Guillou2, Julien Michaud1, Christopher Banse1, Sandra Desouches1, Gilles Avenel3, Quentin Bréhier4, Aurélia Bisson-Vaivre1, Sophie Pouplin1 and Olivier Vittecoq5, 1Rheumatology, Rouen University Hospital, Rouen, France, 2Inserm 905 & Institute for Biomedical Research, University of Rouen, Rouen, France, 3Rheumaotlogy, Rouen University Hospital, Rouen, France, 4Rheumatology, Le Havre Hospital, Le Havre, France, 5Rheumatology, Department of Rheumatology, Rouen University Hospital & Inserm 905, Institute for Biomedical Research, University of Rouen, Rouen, France

    Background/Purpose: Managing axial spondyloarthritis (aSpA) may be difficult because sometimes patients are not good responder to anti-TNF. We made the hypothesis that in certain patients,…
  • Abstract Number: 1303 • 2013 ACR/ARHP Annual Meeting

    Variations In Disease Activity and Therapeutic Management Of Rheumatoid Arthritis In Different International Regions: A Comparison Of Data From The Corrona International and Corrona United States Registries

    Dimitrios A. Pappas1, Kathy Lampl2, Joel M. Kremer3, Sebastião C. Radominski4, Janos Gal5, Fredrik Nyberg6, Anand N. Malaviya7, Aimée Whitworth8, Oscar Luis Rillo9, Allan Gibofsky10, Tatiana Popkova11, Meilien Ho12, Ieda Laurindo13, George W. Reed8, Eduardo Mario Kerzberg14, Laura Horne15, Roman Záhora16, Katherine C. Saunders17, Bernado Pons-Estel18, Alina U. Onofrei19 and Jeffrey D. Greenberg20, 1Columbia University, New York, NY, 2AstraZeneca R&D Wilmington, Wilmington, DE, 3Center for Rheumatology, Albany Medical College, Albany, NY, 4Universidade Federal do Paraná, Curitiba, Brazil, 5Rheumatology, County Hospital, Kecskemet, Hungary, 6AstraZeneca R&D, Mölndal, Sweden, 7Rheumatology, Consultant Rheumatologist, ISIC Superspeciality Hospital, New Delhi-11007-, India, 8CORRONA, Inc., Southborough, MA, 9Hospital Tornú, Capital Federal, Argentina, 10Medicine and Public Health, Hospital for Special Surgery, New York, NY, 11Research Institute of Rheumatology -Russian Academy of Medical Science, Moscow, Russia, 12AstraZeneca R&D Alderley Park, Macclesfield, United Kingdom, 13Rheumatology, Universidade de São Paulo, São Paulo, Brazil, 14Rheumatology, J. M. Ramos Mejía Hospital, School of Medicine, University of Buenos Aires, Buenos Aires, Argentina, 15AstraZeneca, Wilmington, DE, 16Revmatologická ambulance, Terezin, Czech Republic, 17Corrona, LLC., Southborough, MA, 18Hospital Provincial de Rosario, Rosario, Argentina, 19University of Massachusetts Medical School, Worcester, MA, 20Rheumatology, NYU Hospital for Joint Diseases, New York, NY

    Background/Purpose: The CORRONA International (C.Intl) rheumatoid arthritis (RA) registry is the first multinational RA registry uniformly collecting baseline and longitudinal data.  We explored variations in…
  • Abstract Number: 522 • 2013 ACR/ARHP Annual Meeting

    Abatacept Reduces Disease Activity In Early Primary Sjögren’s Syndrome:One Year Results From a Phase II Open-Label Study

    PM Meiners1, A Vissink2, Fkl Spijkervet3, EA Haacke4, WH Abdulahad5, E Brouwer5, MG Huitema5, N Sillevis Smitt-Kamminga6, FGM Kroese7, S Arends5 and H Bootsma5, 1Oral and Maxillofacial Surgery, University Medical Center Groningen, University of Groningen, Groningen, Netherlands, 2Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 3Oral and Maxillofacial Surgery, University Medical Center Groningen, Groningen, Netherlands, 4Pathology, University Medical Center Groningen, Groningen, Netherlands, 5Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, Netherlands, 6Opthalmology, University Medical Center Groningen, Groningen, Netherlands, 7Rheumatology and clinical immunology, University Medical Center Groningen, Groningen, Netherlands

    Background/Purpose: Traditional DMARDs have limited effects in primary Sjögren's (pSS) patients. B cell depletion therapy with rituximab showed efficacy, but had some side-effects. T and…
  • Abstract Number: 2790 • 2013 ACR/ARHP Annual Meeting

    The Research In Arthritis In Canadian Children Emphasizing Outcomes (ReACCh Out) Cohort:  Are We Achieving Clinically Important Outcomes?

    Deborah M. Levy1, Shirley ML Tse1, Elizabeth Stringer2, Jaime Guzman3, Roberta A. Berard4, Karen Watanabe Duffy5, Dax Rumsey1, Mercedes O. Chan3, Rosie Scuccimarri6, Adam M. Huber7, Lori B. Tucker3, Rae SM Yeung1, Ciaran M. Duffy5, Kiem Oen8 and The ReACCh Out Investigators9, 1Rheumatology, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada, 2Department of Rheumatology, IWK Health Centre, Halifax, NS, Canada, 3Rheumatology, BC Children's Hospital and University of British Columbia, Vancouver, BC, Canada, 4Children's Hospital of Western Ontario, London, ON, Canada, 5Rheumatology, Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, 6McGill University, Montreal, QC, Canada, 7Dalhousie University, Halifax, NS, Canada, 8Pediatrics, Children's Hospital of Winnipeg and University of Manitoba, Winnipeg, MB, Canada, 9The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada

    Background/Purpose:  Recent data suggests that achievement of inactive disease and early disease remission may result in improved outcomes for patients with juvenile idiopathic arthritis (JIA). …
  • Abstract Number: 2272 • 2013 ACR/ARHP Annual Meeting

    Patient Survey Regarding Utility Of The Health Assessment Questionnaire Reveals An Unrecognized Aspect Of Disease Activity In Rheumatoid Arthritis: Consequences Of Physical Activity

    Kelly O'Neill Young1, Dana M. Symons1, Andrew T. Lumpe2 and Cynthia S. Crowson3, 1Rheumatoid Patient Foundation, Cocoa, FL, 2Seattle Pacific University, Seattle, WA, 3Department of Health Sciences Research, Mayo Clinic, Rochester, MN

    Patient Survey Regarding Utility of the Health Assessment Questionnaire Reveals an Unrecognized Aspect of Disease Activity in Rheumatoid Arthritis: Consequences of Physical Activity Background/Purpose: The…
  • Abstract Number: 1948 • 2013 ACR/ARHP Annual Meeting

    Power Doppler Ultrasound 7-Joint Score Vs. Simplified Disease Activity Index In Rheumatoid Arthritis Associated With Fibromyalgia

    Rafael Chakr1, Marina Behar2, José A. Mendonça3, Daniela Cervantes2, Nizele Calegaro2, Nicole Andrade2, Iuri Siqueira2, Daniel Zanchet2, Andrese Gasparin2, Penélope Esther Palominos2, Charles Kohem4, Odirlei Andre Monticielo5, Claiton Brenol6, Ricardo M. Xavier2 and João Carlos T. Brenol7, 1Rheumatology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil, 2Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil, 3Rheumatology, Pontifical Catholic University of Campinas / Institute of Clinical Research – IPECC, Campinas, Brazil, 4Brazilian Registry of Spondyloarthritis, São Paulo, Brazil, 5Department of Internal Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil, 6Universidade Federal do Rio Grande do Sul, Porto Alegre RS, Brazil, 7Rheumatology Division, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil

    Background/Purpose: Fibromyalgia (FM) falsely increases rheumatoid arthritis (RA) disease activity clinical composite scores, such as the simplified disease activity index (SDAI), recently incorporated into ACR/EULAR…
  • Abstract Number: 1453 • 2013 ACR/ARHP Annual Meeting

    Repeated High Or Low Multi-Biomarker Disease Activity (VECTRA® DA Algorithm) Scores Associated With Radiographic Outcomes In Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors

    Shintaro Hirata1, Wanying Li2, Nadine A. Defranoux2, Rebecca Bolce2, Eric H. Sasso2, Satoshi Kubo1, Shunsuke Fukuyo1, Kentaro Hanami3, Kunihiro Yamaoka1, Kazuyoshi Saito1 and Yoshiya Tanaka1, 1The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 2Crescendo Bioscience Inc., South San Francisco, CA, 3The first department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan

    Background/Purpose: A novel multi-biomarker disease activity (MBDA) score that is based on the serum concentrations of 12 biomarkers has been shown to correlate with clinical…
  • Abstract Number: 1272 • 2013 ACR/ARHP Annual Meeting

    Whole-Body Versus Thigh Magnetic Resonance Imaging In The Assessment Of Juvenile Dermatomyositis

    Clara Malattia1, Annalisa Madeo2, Marta Dellepiane3, Diliana Beleva3, Stefania Viola4, Alessandro Consolaro5, Nicolino Ruperto1 and Alberto Martini6, 1PRINTO, Genoa, Italy, 2Istituto G Gaslini, Pediatria II, Reumatologia, Genova, Italy, 3Istituto G. Gaslini, Pediatria 2, Genoa, Italy, 4Istituto G. Gaslini, Istituto Giannina Gaslini, Genova, Italy, 5Pediatria II, Istituto Giannina Gaslini, Genova, Italy, 6Istituto Giannina Gaslini, Pediatria II, Reumatologia, Paediatric Rheumatology International Trials Organisation (PRINTO) Coordinating Center, Genoa, Italy, Genoa, Italy

    Background/Purpose: MRI is a promising tool to assess disease activity in juvenile dermatomyositis (JDM). So far all MRI JDM studies focused on the thigh musculature.…
  • Abstract Number: 468 • 2013 ACR/ARHP Annual Meeting

    The Differential Role Of T Helper Cells In The Pathogenesis and Responsiveness To Abatacept Therapy In Rheumatoid Arthritis

    Shunsuke Fukuyo1, Shingo Nakayamada2, Kunihiro Yamaoka1, Satoshi Kubo1, Shigeru Iwata3, Kazuyoshi Saito1 and Yoshiya Tanaka1, 1The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 2First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 3The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan, Kitakyushu, Japan

    Background/Purpose: Abatacept (ABT) works through a different mechanism of action from TNF inhibitors in the treatment of rheumatoid arthritis (RA). ABT decreases T cell responses…
  • Abstract Number: 2681 • 2013 ACR/ARHP Annual Meeting

    Reduced Fertility In Women With Rheumatoid Arthritis: Influence Of Disease Activity and Medication Use

    Jenny Brouwer1,2, Johanna MW Hazes1, Joop SE Laven2 and Radboud JEM Dolhain1, 1Rheumatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands, 2Obstetrics & Gynaecology, division of Reproductive Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands

    Background/Purpose: Many female rheumatoid arthritis (RA) patients who try to conceive have a time to pregnancy (TTP) longer than 12 months.  During this period RA…
  • Abstract Number: 2273 • 2013 ACR/ARHP Annual Meeting

    Patient Survey Challenges Conventional Notions Regarding Symptoms and Experiences Of People Living With Rheumatoid Arthritis

    Kelly O'Neill Young1, Cynthia S. Crowson2 and Dana M. Symons1, 1Rheumatoid Patient Foundation, Cocoa, FL, 2Department of Health Sciences Research, Mayo Clinic, Rochester, MN

    Background/Purpose: While rheumatoid arthritis (RA) has been studied for decades, many aspects of the disease are not well understood. Like systemic lupus erythematosus, RA manifests…
  • Abstract Number: 1877 • 2013 ACR/ARHP Annual Meeting

    A Neutrophil Signature Comprised Of Low Density Granulocyte (LDG)-Enriched Genes Is Associated With Organ-Specific Disease Activity In Systemic Lupus Erythematosus

    Michelle Petri1, Hong Fang1, Jadwiga Bienkowska2, Andrea Dearth3, Norm Allaire4 and Ann Ranger3, 1Johns Hopkins University School of Medicine, Baltimore, MD, 2Translational Medicine, Biogen Idec Inc., Cambridge, MA, 3Biogen Idec Inc, Cambridge, MA, 4Biogen Idec Inc., Cambridge, MA

    Background/Purpose: The neutrophil gene signature (NGS) has recently gained interest due to new understanding of the role of neutrophils and NETosis in SLE pathogenesis. We…
  • Abstract Number: 1425 • 2013 ACR/ARHP Annual Meeting

    Discontinuation Of Tumor Necrosis Factor Inhibitors In Rheumatoid Arthritis Patients In Low Disease Activity: Persistent Benefits

    Arthur Kavanaugh1, Susan J. Lee2,3, Daniel H. Solomon4, Jeffrey D. Greenberg5, Joel M. Kremer6, Lilian Soto7, Carol J. Etzel8,9 and George W. Reed10, 1University of California, San Diego, La Jolla, CA, 2University of California San Diego, La Jolla, CA, 3San Diego Veterans Affairs Medical Center, San Diego, CA, 4Division of Pharmacoepidemiology, Harvard Medical School, Brigham and Women's Hospital, Division of Rheumatology, Division of Pharmacoepidemiology, Boston, MA, 5NYU Hospital for Joint Diseases, New York, NY, 6Center for Rheumatology, Albany Medical College, Albany, NY, 7University of California San Diego, San Diego, CA, 8Department of Epidemiology, UT MD Anderson, Houston, TX, 9PO Box 786, Corrona, LLC., Southborough, MA, 10Corrona, LLC., Southborough, MA

    Background/Purpose: A key question is whether biologic agents can be stopped but clinical benefit maintained for rheumatoid arthritis (RA) patients (pts) in remission or low…
  • Abstract Number: 1103 • 2013 ACR/ARHP Annual Meeting

    Brain Derived Neurotrophic Factor Is Elevated In Patients With Rheumatoid Arthritis and Secondary Fibromyalgia

    Able Lawrence, Venkatesh Pai, Rajni Srivastava, Vikas Agarwal, Ramnath Misra and Amita Aggarwal, Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

    Background/Purpose: Secondary Fibromyalgia is seen in 15% of patients with rheumatoid arthritis (RA). Neurotrophins are elevated in patients with active arthritis and BDNF is elevated…
  • « Previous Page
  • 1
  • …
  • 95
  • 96
  • 97
  • 98
  • 99
  • …
  • 102
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology